Vir Biotechnology (VIR) EBT Margin (2018 - 2026)
Vir Biotechnology (VIR) reported EBT Margin of 33.59% for Q2 2026, up 9159.45 percentage points from -9125.86% a year earlier and up 432878.42 percentage points from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) EBT Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vir Biotechnology's EBT Margin came in at -82.86%, up 2811.63 percentage points year-over-year; for FY2025, it came in at -638.56%, up 66.39 percentage points from FY2024.
- EBT Margin has a five-year change of -247.54 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -704.95% in FY2024 (+23.99 pp), -728.93% in FY2023 (-775.61 pp), 46.68% in FY2022 (-3.51 pp) and 50.19% in FY2021 (+441.21 pp).
- The Q2 2026 figure ranks as the highest quarterly EBT Margin since Q3 2022.
- Year over year, EBT Margin gained in two of the last eight quarters, with an average year-over-year change of -61135.75 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2026 (a gain of 9159.45 percentage points); the low point was Q1 2026 (a drop of 428855.74 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -432844.83% (Q1 2026), -67.21% (Q4 2025) and -67905.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn | 33.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.59% |
| Mar 31, 2026 | -432,844.83% |
| Dec 31, 2025 | -67.21% |
| Sep 30, 2025 | -67,905.42% |
| Jun 30, 2025 | -9,125.86% |
| Mar 31, 2025 | -3,989.08% |
| Dec 31, 2024 | -845.93% |
| Sep 30, 2024 | -8,972.27% |
| Jun 30, 2024 | -4,549.27% |
| Mar 31, 2024 | -115.30% |
| Dec 31, 2023 | -719.35% |
| Sep 30, 2023 | -6,313.98% |
| Jun 30, 2023 | -5,204.71% |
| Mar 31, 2023 | -227.44% |
| Dec 31, 2022 | -306.90% |
| Sep 30, 2022 | 58.13% |
| Jun 30, 2022 | -575.26% |
| Mar 31, 2022 | 74.80% |
| Dec 31, 2021 | 67.17% |
| Sep 30, 2021 | 106.90% |
API Access
Vir Biotechnology EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();